Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Inovio Pharma
(NQ:
INO
)
7.220
-0.100 (-1.37%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Inovio Pharma
< Previous
1
2
3
4
5
6
7
8
Next >
Benzinga's Top Ratings Upgrades, Downgrades For January 21, 2022
January 21, 2022
Upgrades According to Seaport Global, the prior rating for KB Home (NYSE:
Via
Benzinga
10 Biggest Price Target Changes For Friday
January 21, 2022
Barclays cut Netflix, Inc. (NASDAQ: NFLX) price target from $675 to $425. Netflix shares fell 19.6% to $408.58 in pre-market trading. Keybanc cut Chipotle Mexican Grill, Inc...
Via
Benzinga
Bill Gates Says Misinformation Related To Fauci, Himself Doesn't 'Make Sense,' Talks COVID-19 After Omicron
January 11, 2022
Microsoft Corporation (NASDAQ: MSFT) co-founder Bill Gates answered questions related to COVID-19 on Twitter Tuesday. What Happened: The questions to Gates were routed through...
Via
Benzinga
Stocks Hitting New 52-Week Lows Today
January 03, 2022
On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was...
Via
Benzinga
Wingstop, Akamai Initiations Among Today's Top Calls On Wall Street
December 29, 2021
Benchmark analyst Todd Brooks initiated coverage of Wingstop (WING) with a Hold rating and no price target. The analyst believes the stock's risk/reward is balanced at these levels given the current
Via
Talk Markets
If You Invested $1,000 In Inovio Stock One Year Ago, Here's How Much You'd Have Now
December 27, 2021
Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return over the last 12 months is 29.2...
Via
Benzinga
Market Briefing For Thursday, Dec. 23
December 23, 2021
'Fortune favors the brave' it is said; it's partially so in this market, where we certainly got the ignition Tuesday of the seasonal rebound we looked for and more on Wednesday.
Via
Talk Markets
Why Jim Cramer Likes MGM Growth Properties
December 21, 2021
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Enterprise Products Partners L.P. (NYSE:
Via
Benzinga
Why You Should Buy Moderna Stock at Every Dip
December 10, 2021
Moderna’s cash growth will continue as demand for booster shots and vaccines for the omicron variant increase, giving a boost to MRNA stock.
Via
InvestorPlace
Exposures
COVID-19
Here's Why These 3 COVID-19 Vaccine Stocks Got Crushed This Week
December 03, 2021
These second-tier COVID-19 vaccine players plunged due to fears about the potential impacts of the omicron variant.
Via
The Motley Fool
Exposures
COVID-19
The 'Highly Mutated Virus' Signals A Need For Annual Shots: BioNTech CEO
December 03, 2021
The omicron variant signals a need for annual Covid shots, BioNTech's CEO said.
Via
Investor's Business Daily
2 Stocks That Are Down 60% (or More) From Their 52-Week Highs
December 03, 2021
One of these stocks is poised to rebound, but the other still looks very risky.
Via
The Motley Fool
Topics
Economy
Exposures
COVID-19
Economy
Adagio Continues Its Run As Biotech Stocks Moderna, BioNTech Dive On Omicron Threat
November 30, 2021
Biotech stocks diverged Tuesday with Adagio continuing a run on the potential for its antibody to target Covid's omicron variant.
Via
Investor's Business Daily
Vaccine Stocks Ask The Unthinkable: What Happens If Today's Covid Shots Fail?
November 29, 2021
Smaller companies are working on next-generation approaches to Covid treatment.
Via
Investor's Business Daily
20 Stocks Moving in Monday's Pre-Market Session
November 29, 2021
Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 85.6% to $3.88 in pre-market trading after jumping 14% on Friday. Petros Pharmaceuticals recently said Q3 sales results...
Via
Benzinga
Novavax Working On New COVID-19 Vaccine To Combat Omicron Variant
November 29, 2021
Novavax Inc (NASDAQ: NVAX) said it had started working on a version of its COVID-19 vaccine to target the variant detected in South Africa. It said that the shot would be...
Via
Benzinga
Exposures
COVID-19
Battle of the COVID Vaccine Contenders: Inovio vs. Ocugen
November 21, 2021
Both vaccine makers still have big hurdles to jump.
Via
The Motley Fool
Exposures
COVID-19
Does This News Make Inovio Pharmaceuticals Stock a Buy?
November 17, 2021
The company is closer than ever to launching its coronavirus vaccine -- but will it be good enough to make the stock worth purchasing?
Via
The Motley Fool
Exposures
COVID-19
Why Inovio Stock Is Rising Today
November 10, 2021
The company received a green light to begin a U.S. phase 3 study of its COVID-19 vaccine candidate.
Via
The Motley Fool
Exposures
COVID-19
Product Safety
Inovio Pharmaceuticals (INO) Q3 2021 Earnings Call Transcript
November 10, 2021
INO earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Inovio Pharmaceuticals Sees A Bounce Off Support After COVID-19 Vaccine News
November 09, 2021
Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Tuesday after the FDA removed a hold on the company’s late-stage COVID-19 vaccine trial in the U.S....
Via
Benzinga
Exposures
COVID-19
Product Safety
Why Shares of Inovio Pharmaceuticals Rallied Today
November 09, 2021
The FDA lifted its hold on the next step of its COVID-19 vaccine trial, although that doesn't mean much at this point.
Via
The Motley Fool
Exposures
COVID-19
Product Safety
RBLX Stock Alert: What Is Going on With Roblox Shares Today?
November 09, 2021
Roblox (RBLX) stock is soaring higher on Tuesday following the release of the company's earnings report for the third quarter of 2021.
Via
InvestorPlace
INO Stock: The Covid-19 Vaccine News Helping Inovio Power Higher
November 09, 2021
Inovio Pharmaceuticals (INO) stock is pushing higher on Tuesday after providing investors with an update on its Covid-19 vaccine.
Via
InvestorPlace
Exposures
COVID-19
FDA Lifts Clinical Hold On Inovio's COVID-19 Vaccine Trial
November 09, 2021
The FDA has lifted a partial clinical hold on a late-stage trial of Inovio Pharmaceuticals Inc's (NASDAQ: INO) COVID-19 vaccine in the U.S. Inovio said it...
Via
Benzinga
Exposures
COVID-19
Product Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 09, 2021
Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the...
Via
Benzinga
AstraZeneca's Medimmune Terminates DNA Cancer Vaccine Program With Inovio
November 01, 2021
MedImmune Limited, a unit of AstraZeneca Plc (NASDAQ: AZN), has notified Inovio Pharmaceuticals Inc (NASDAQ: INO) to terminate the DNA cancer vaccine...
Via
Benzinga
Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage
October 18, 2021
Vaccine makers have been under tremendous selling pressure over the past 2 months driven by policy, the rising delta wave, and breakthrough infections. This slump has been a boost for the oral...
Via
Talk Markets
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.